Filippo de Braud

Filippo de Braud

UNVERIFIED PROFILE

Are you Filippo de Braud?   Register this Author

Register author
Filippo de Braud

Filippo de Braud

Publications by authors named "Filippo de Braud"

Are you Filippo de Braud?   Register this Author

100Publications

2219Reads

19Profile Views

Should we use combination therapy for all advanced renal cell carcinoma?

Lancet Oncol 2019 Oct 16;20(10):1331-1332. Epub 2019 Aug 16.

Medical Oncology Unit, Fondazione IRCSS Istituto Nazionale dei Tumori di Milano, Milan 20133, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30518-2DOI Listing
October 2019

The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells.

Semin Cancer Biol 2019 Oct 15. Epub 2019 Oct 15.

Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2019.10.008DOI Listing
October 2019

Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis.

Oncol Res Treat 2019 5;42(4):186-194. Epub 2019 Mar 5.

Department of Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000497211DOI Listing
September 2019

Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectives.

Cancer Treat Rev 2019 Sep 27;79:101891. Epub 2019 Aug 27.

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2019.101891DOI Listing
September 2019

Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations.

Pancreatology 2019 Sep 30. Epub 2019 Sep 30.

NET Team Bologna ENETS Center of Excellence, Department of Medical and Surgical Sciences, S. Orsola-Malpighi University Hospital, Alma Mater Studiorum University of Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pan.2019.09.015DOI Listing
September 2019

Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors.

Front Oncol 2019 20;9:902. Epub 2019 Sep 20.

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.00902DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763756PMC
September 2019

Artificial Intelligence Estimates the Importance of Baseline Factors in Predicting Response to Anti-PD1 in Metastatic Melanoma.

Am J Clin Oncol 2019 Aug;42(8):643-648

Department of Medical Oncology and Hematology, Melanoma Medical Oncology Unit.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000566DOI Listing
August 2019

Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy.

Future Oncol 2019 Aug 24;15(23):2743-2757. Epub 2019 Jul 24.

Department of Medical Oncology, Unit of Thoracic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, via G Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0055DOI Listing
August 2019

Developing a score system to predict therapeutic outcomes to anti-PD-1 immunotherapy in metastatic melanoma.

Tumori 2019 Aug 26:300891619868009. Epub 2019 Aug 26.

1 Melanoma Medical Oncology Unit, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300891619868009DOI Listing
August 2019

Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer.

Tumori 2019 Aug 28:300891619872546. Epub 2019 Aug 28.

1 Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300891619872546DOI Listing
August 2019

The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice.

Int J Mol Sci 2019 Aug 30;20(17). Epub 2019 Aug 30.

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20174263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747319PMC
August 2019

The role of metastasectomy in advanced renal cell carcinoma.

Expert Rev Anticancer Ther 2019 Jul 8;19(7):603-611. Epub 2019 Jun 8.

a Medical Oncology Department , Fondazione IRCCS Istituto Nazionale dei Tumori , Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2019.1625772DOI Listing
July 2019

Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component.

Clin Colorectal Cancer 2019 Jun 7;18(2):116-124. Epub 2019 Mar 7.

Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2019.02.007DOI Listing
June 2019

Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei.

Clin Colorectal Cancer 2019 Jun 1;18(2):e179-e190. Epub 2019 Apr 1.

Medical Oncology Department, Istituto Nazionale dei Tumori di Milano, Fondazione IRCCS, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2019.03.002DOI Listing
June 2019

Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer.

Lung Cancer 2019 Jun 8;132:72-78. Epub 2019 Apr 8.

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, via G. Venezian 1, 20133, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.04.008DOI Listing
June 2019

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles.

Clin Breast Cancer 2019 Apr 12;19(2):e306-e318. Epub 2018 Dec 12.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy; Oncology and Haemato-Oncology Department, University of Milan, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2018.12.004DOI Listing
April 2019

Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma.

J Cancer Res Clin Oncol 2019 Feb 11;145(2):511-521. Epub 2018 Dec 11.

Melanoma Medical Oncology Unit, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-018-2819-xDOI Listing
February 2019

Bilateral parotid gland metastases from gastric signet-ring cell carcinoma.

Tumori 2018 Dec 8;104(6):NP10-NP13. Epub 2018 May 8.

1 Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/tj.5000690DOI Listing
December 2018

Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?

Breast 2018 Dec 29;42:68-73. Epub 2018 Aug 29.

Department of Medical Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2018.08.106DOI Listing
December 2018

Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

Target Oncol 2018 10;13(5):567-582

Department of Medical Oncology Unit-1, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano and ENETS Center of Excellence, Via Venezian 1, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-018-0585-yDOI Listing
October 2018

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer.

J Clin Oncol 2018 10 15;36(28):2836-2844. Epub 2018 Aug 15.

Yelena Y. Janjigian, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Johanna Bendell, Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN; Emiliano Calvo, START Madrid, Centro Integral Oncológico Clara Campal, Madrid, Spain; Joseph W. Kim, Yale Cancer Center, New Haven, CT; Paolo A. Ascierto, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples; Filippo de Braud, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy; Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, TX; Patrick A. Ott, Dana-Farber Cancer Institute, Boston, MA; Katriina Peltola, Docrates Cancer Center, Helsinki, Finland; Dirk Jaeger, University Hospital Heidelberg, Heidelberg, Germany; Jeffry Evans, University of Glasgow, Glasgow; Ian Chau, Royal Marsden Hospital, London and Surrey, United Kingdom; Christopher T. Harbison, Cecile Dorange, Marina Tschaika, Bristol-Myers Squibb, Princeton, NJ; and Dung T. Le, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.6212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161834PMC
October 2018

Immunotherapy-based combinations: an update.

Curr Opin Oncol 2018 09;30(5):345-351

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000466DOI Listing
September 2018

Exposure to Multiple Lines of Treatment and Survival of Patients With Metastatic Renal Cell Carcinoma: A Real-world Analysis.

Clin Genitourin Cancer 2018 08 5;16(4):e735-e742. Epub 2018 Feb 5.

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2018.01.016DOI Listing
August 2018

Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies.

Pharmacogenomics 2018 08 25;19(13):1047-1068. Epub 2018 Jul 25.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2018-0077DOI Listing
August 2018

The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review.

Target Oncol 2018 06;13(3):333-351

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11523-018-0567-0
Publisher Site
http://dx.doi.org/10.1007/s11523-018-0567-0DOI Listing
June 2018

Combination therapies for patients with metastatic renal cell carcinoma.

Lancet Oncol 2018 03 10;19(3):281-283. Epub 2018 Feb 10.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30092-5DOI Listing
March 2018

Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectives.

Crit Rev Oncol Hematol 2018 Mar 2;123:57-73. Epub 2018 Feb 2.

Medical Oncology and Hematology Department, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian, 1, 20133, Milan, Italy; Universita' degli Studi di Milano, 20122, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2018.01.002DOI Listing
March 2018

Clinical implications for pro-GRP in small cell lung cancer. A single center experience.

Int J Biol Markers 2018 Jan;33(1):55-61

1 Medical Oncology Department - National Cancer Institute of Milan - Fondazione IRCCS Istituto Nazionale Tumori, Milan - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/ijbm.5000305DOI Listing
January 2018

Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors: A case series and literature review.

Lung Cancer 2018 01 5;115:135-142. Epub 2017 Dec 5.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale di Tumori, via G. Venezian 1, 20133, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.12.002DOI Listing
January 2018

Uncommon somatic mutations in metastatic NUT midline carcinoma.

Tumori 2017 Nov 15;103(Suppl. 1):e5-e8. Epub 2017 Nov 15.

Medical Oncology Department, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/tj.5000685DOI Listing
November 2017

Cognitive impairment and chemotherapy: a brief overview.

Crit Rev Oncol Hematol 2017 Oct 14;118:7-14. Epub 2017 Aug 14.

Medical Oncology Department, Fondazione IRCCS Istituto Nazionale di Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2017.08.001DOI Listing
October 2017

Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors.

Future Oncol 2017 Aug 5;13(19):1677-1683. Epub 2017 Jun 5.

Department of Medical Oncology, Unit 1, ENET Center of Excellence, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon-2017-0132
Publisher Site
http://dx.doi.org/10.2217/fon-2017-0132DOI Listing
August 2017

"Systemic strategy at the patient's service": a congress report on supportive care in oncology.

Tumori 2017 Jul 27. Epub 2017 Jul 27.

Medical Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/TJ.2017.17342DOI Listing
July 2017

The underestimated role of somatostatin analogs in the NETTER-1 trial.

Future Oncol 2017 06 11;13(15):1287-1289. Epub 2017 May 11.

Department of Medical Oncology Unit 1, GEP-ENETS Center of Excellence, "Istituto Nazionale Tumori", Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0130DOI Listing
June 2017

HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature.

Breast Care (Basel) 2016 Dec 9;11(6):424-426. Epub 2016 Dec 9.

Department of Medical Oncology, Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000453572DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290429PMC
December 2016